PATENT CLAIM ANALYSIS

Application Number: 15984993
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "158100"]

Abstract:
The present invention relates to a method for treating or alleviating the symptoms of peripheral arterial disease (PAD) in a subject, comprising administering about 25 mg to about 300 mg of an IL-1β binding antibody or functional fragment thereof.

Claim (Index 12):
The method according to  claim 1 , wherein the formulation is disposed within a pre-filled syringe, vial, or autoinjector.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.16216
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14442536', '14347071', '15359784', '13955673', '14861191']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7650755959667421
- 35 USC 102 Novelty (BERT): 0.5374316237558521
- Combined Prediction Score: 0.7423111987456531
- Mean Citation Score: 311.903526
- Max Citation Score: 380.54147
- Similarity Product: 236.1905459243196

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test